Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer
M Peate, B Meiser, BC Cheah, C Saunders, P Butow, B Thewes, R Hart, K-A Phillips, M Hickey, M Friedlander
BRITISH JOURNAL OF CANCER | NATURE PUBLISHING GROUP | Published : 2012
Awarded by Cancer Council, New South Wales
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Awarded by NHMRC
We would like to thank the all the women who participated in this study and the oncology clinic staff at each study site for their assistance with participant recruitment. Furthermore, we would like to acknowledge the Australian Fertility Decision Aid Collaborative Group for their contribution to the study. The additional members of the Australian Fertility Decision Aid Collaborative Group are (in alphabetical order of institute): Calvary Health Care ACT (B Holley, J McGuiggan, M McNair); Concord Hospital (K Kerin-Ayres, H Wiese); Goulburn Valley Health (K Patford); Liverpool Hospital (AM Griffin); Mount Medical Centre (C Griffiths); Peter MacCallum Cancer Institute (T Griffiths, J McGirr, S Pratt); Prince of Wales Hospital (G Neil, S Rovelli, C Wakefield); Royal Adelaide Hospital (J Iasiello); Royal Brisbane and Women's Hospital (W Pritchard); Royal North Shore Hospital (M Arvin, T Cosgrove); Royal Perth Hospital (L Kydd, S Reid); Royal Prince Alfred Hsopital (A Carrigy, K Robinson, R Wicks); Sir Charles Gairdiner (S Boyle, L O'Brien, K O'Driscoll, L Wilson); St George Hospital (E Carrusca, R Hannan, A Szwajcer); St Vincent's Hospital (K Aylward, S Stewart, S Turley); St Vincent's Hospital (D Maguire); Shoalhaven Hospital (M Brien); Strathfield Breast Centre (R Martin); The Mater Hospital (F Boyle, C John, K Watts); University of Western Australia (J Fallon-Ferguson); Westmead Hospital (L Black, J Cooper, M Sweeny, R Winter); Wollongong Hospital (J Hollis, L Horning, R Mikleus, V Millwood, G Swift); and Young Breast Cancer Action Group (R Martinello, K Parkinson). The study was funded by The Cancer Council, New South Wales (Project Grant RG 06-13). Bettina Meiser is supported by a Career Development Award from the National Health and Medical Research Council of Australia (NHMRC; ID 350989 and 1003921) and a Cancer institute NSW Career Development Fellowship. Kelly-Anne Phillips is the Cancer Council Victoria Colebatch Clinical Research Fellow. Martha Hickey holds a NHMRC Clinical Career Development Award from the NHMRC (404094). This trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12605000402640).